10.07.2015 Views

043-056-Vlado Trajkovski-medicinski tretman - Journal of Special ...

043-056-Vlado Trajkovski-medicinski tretman - Journal of Special ...

043-056-Vlado Trajkovski-medicinski tretman - Journal of Special ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MEDICAL TREATMENTdeka lekovite ne se zameni za drugite vi -dovi <strong>tretman</strong> na autizmot. Golem broj decaso primena na ovie lekovi stanuvaat pomirni,pomalku hiperaktivni, so zgolemenovnimanie, reducirana agresija i avtoagresija,dodeka nezainteresiranite deca stanuvaatpootvoreni.Analiziranite vidovi bio<strong>medicinski</strong> terapiimo`ebi, u{te nemaat doka`ana vrednost,no vo nekoi studii imale pozitivnirezultati, odnosno vodele kon podobruvawena autisti~nata simptomatologija. Sekako,potrebni se natamo{ni istra`uvawa zaradidoutvrduvawe na vistinskata vrednost naovie lekovi. Vo na{ata sredina mnogu odnavedenite lekovi voop{to ne se zemaat.Zatoa se nametnuva potrebata od po~nuvawena terapijata na autizmot so nekoj od ovievidovi <strong>tretman</strong> i vo na{ava dr`ava.replacement for other kinds <strong>of</strong> treatment <strong>of</strong> autism.A large number <strong>of</strong> children with implementatio n <strong>of</strong>this medicine become calmer, less hyperactive,with increased attention, reduced aggression andself-aggression, while uninterested children becomeopener.The analyzed types <strong>of</strong> biomedical therapies mightnot have approved value, but they showed pos itiveresults in some studies, i.e. they led towards im -provement <strong>of</strong> autistic symptoms. Certainly, furtherresearch is needed in order to determine the realvalue <strong>of</strong> the medicine. A great number <strong>of</strong> listedmedicines are not used in our country. Therefore, itis necessary to start therapy in autism with sometypes <strong>of</strong> these treatments.Literatura / References1. American Psychiatric Association. Diagnostic andstatistical manual <strong>of</strong> mental disorders (4 thed.), Waschington,DC, 1994.2. Posey DJ and McDougle CJ. Pharmacotherapeuticmanagement <strong>of</strong> autism. Exp Opin Pharmacother 2001; 2(4): 587 -600.3. Winslow JT and Insel TR. The social deficits <strong>of</strong> theoxytocin knockout mouse. Neuropeptides 2002; 36: 221-229.4. Modahl C, Green L, Fein D, Morris M, WaterhouseL, Feinstein C, & Levin H. Plasma oxytocin levels inautistic children. Biol Psychiatry 1998; 43: 270-277.5. Hollander E, Novotny S, Hanratty M, Yaffe R, De-Caria CM, Aronowitz BR and Mosovich S. Oxytocininfusion reduces repetitive behavior in adults with au tisticand Asperger’s disorders. Neuropsychopharmacology2003; 28: 193 -198.6. Fernell E, Watanabe Y, Adolfsson I, Tani Y,Bergstrom M, Hartvig P, Lilja A, von Knorring AL,Gillberg C, and Langstrom B. Possible effects <strong>of</strong> tetrahydrobiopterintreatment in six children with autismclinicaland positron emission tomography data: a pilotstudy. Developmental Medicine and Child Neurology1997; 39: 313 -318.7. Danysz W. CX-516 Cortex pharmaceuticals. CurrentOpinion in Investigational Drugs 2002; 3 (7) : 1081-1088.8. Whitman TL, and Kolberg KJ. Educational and BiomedicalInterventions. In: Whitman TL, ed. The development<strong>of</strong> autism a self-regulatory perspective. JessicaKingsley Publishers, London and New York, 2004; Ch 5:176-233.9. Beck G, Beck V, and Rimland B. Unlocking the potential<strong>of</strong> secretin. San Diego, 1998: The Autism ResearchInstitute.10. Kern JK , Miller VS , Evans PA, and Trivedi MH.Efficacy <strong>of</strong> porcine secretin in children with autism andpervasive developmental disorder. <strong>Journal</strong> <strong>of</strong> Autism andDevelopmental Disorders 2002; 32 (3): 153-160.11. Shaw W. Yeasts and fungi. How to control them. In:William Shaw, editor: Biological Treatments for Autismand PDD. The Great Plains Laboratory, Inc; 2000: 66-94.12. Rimland B. The use <strong>of</strong> vitamin B6, magnesium, andDMG in the treatment <strong>of</strong> autistic children and adults. In:William Shaw, editor: Biological Treatments for Autismand PDD. The Great Plains Laboratory, Inc; 2000: 176-195.13. Dolske MC, Spollen J, McKay S , Lancashire E, andTolbert L. A preliminary trial <strong>of</strong> ascorbic acid as supplementaltherapy for autism. Progress in Neuropsychopharmacologyand Biological Psychiatry 1993; 17:765-774.14. Rimland B. What is the right dosage for Vitamin B6,DMG, and other nutrients useful in autism? Autism ResearchReview International 1997; 11 (4): 3.15. Ziegler C, et al. Alpha-lipoic acid in the treatment <strong>of</strong>diabetic neuropathy in Germany: current evidence fromclinical trials. Experimental & Clinical Endocrinology &Diabetes 1999; 107 (7): 421-430.16. Selakovic M. Autizam i dijeta. Brošura za roditelje.Beograd, 2001; 4-5.56JOURNAL OF SPECIAL EDUCATION AND REHABILITATION 2004; 3-4: 43-56

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!